Holen Sie sich die Stockscreener-App
7.83
8.00%
0.58
Vorhandelsmarkt:
7.59
-0.24
-3.07%
Schlusskurs vom Vortag:
$7.25
Offen:
$7.23
24-Stunden-Volumen:
332.32K
Relative Volume:
0.72
Marktkapitalisierung:
$73.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.17M
KGV:
-0.7726
EPS:
-10.1344
Netto-Cashflow:
$-82.84M
1W Leistung:
+29.64%
1M Leistung:
-76.00%
6M Leistung:
-50.60%
1J Leistung:
-83.25%
1-Tages-Spanne:
$7.16
$7.97
1-Wochen-Bereich:
$5.92
$7.97
52-Wochen-Spanne:
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
Korro Bio Inc
Sektor
Branche
Telefon
617-468-1999
Adresse
60 FIRST STREET, CAMBRIDGE
Vergleichen Sie KRRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
7.83 | 68.28M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-13 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-08-14 | Eingeleitet | William Blair | Outperform |
| 2024-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-11-10 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
| 2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2020-07-14 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Eingeleitet | Cowen | Outperform |
| 2019-10-28 | Eingeleitet | Goldman | Buy |
| 2019-10-28 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Stocks of Korro Bio Inc (KRRO) are poised to climb above their peers - Setenews
Is Korro Bio Inc a good long term investmentCapital Gains Strategies & Small Entry Cost Stocks - earlytimes.in
Will Magenta Lifecare Limited Stock Continue to Outperform in YEARInsider Trading Activity & Market Volatility Strategies - earlytimes.in
Can Korro Bio Inc. stock surprise with earnings upsideGDP Growth & Weekly Return Optimization Plans - BỘ NỘI VỤ
Will Korro Bio Inc. stock continue dividend increasesJuly 2025 Summary & Trade Opportunity Analysis - BỘ NỘI VỤ
Three new option listings and fifteen option delistings on October 21st - MSN
Korro Bio, Inc. Experiences Revision in Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Hold” from Analysts - Defense World
Its Stock Has Paid Off Big Time For Korro Bio Inc - Setenews
Korro Bio’s RNA Editing Ambitions Take A Hit After Trial Blowup - Finimize
Would You Still Hold Korro Bio Stock If It Fell Another 30%? - Trefis
Korro Bio downgraded to Perform from Outperform at Oppenheimer - MSN
What high frequency data says about Korro Bio Inc.Portfolio Profit Report & Daily Oversold Bounce Ideas - newser.com
Will Korro Bio Inc. stock benefit from automationBear Alert & Technical Analysis for Trade Confirmation - newser.com
What indicators show strength in Korro Bio Inc.Portfolio Value Report & Consistent Income Trade Recommendations - newser.com
Will Korro Bio Inc. stock deliver strong dividend growthPortfolio Performance Summary & Growth Focused Investment Plans - newser.com
What makes Korro Bio Inc. stock attractive to growth fundsJuly 2025 News Drivers & Weekly High Return Stock Forecasts - newser.com
What is the fair value of Korro Bio Inc. stock nowJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Korro Bio, Inc.Common Stock (NQ: KRRO - FinancialContent
FY2025 EPS Estimates for Korro Bio Raised by HC Wainwright - Defense World
Korro Bio (KRRO) Price Target Decreased by 30.76% to 66.30 - MSN
Korro Bio stock fell after missing expectations in early stage KRRO-110 trial - MSN
How to track smart money flows in Korro Bio Inc.July 2025 Catalysts & Community Consensus Stock Picks - newser.com
Why Korro Bio Inc. stock is favored by pension fundsWeekly Trend Recap & Community Trade Idea Sharing Platform - newser.com
Can Korro Bio Inc. stock hit record highs againWeekly Trade Summary & Real-Time Sentiment Analysis - newser.com
Published on: 2025-11-16 03:17:25 - newser.com
StockWatch: Korro Craters 81% on Data; Patient Death Sours Analysts on Intellia - Genetic Engineering and Biotechnology News
William Blair Downgrades Korro Bio (KRRO) - MSN
Will Korro Bio Inc. stock attract more institutional investorsPortfolio Performance Summary & Fast Moving Trade Plans - newser.com
Korro Bio Reports Increased Losses Amid Strategic Developments - MSN
Wall Street Zen Upgrades Korro Bio (NASDAQ:KRRO) to Hold - Defense World
Korro Bio downgraded to Neutral from Buy at Chardan - MSN
Korro Bio downgraded to Neutral from Overweight at Cantor Fitzgerald - MSN
Korro Bio downgraded to Market Perform from Strong Buy at Raymond James - MSN
Korro Bio (KRRO): Assessing Valuation After Clinical Setbacks, Layoffs, and Strategic Pivot - Yahoo Finance
Why Korro Bio (KRRO) Is Down 80.0% After Restructuring, Clinical Trial Miss, and CMO Resignation - simplywall.st
Korro Bio Inc. (KRRO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Healthcare Stocks Tumble As Companies Shift Strategies - Finimize
Korro Bio Pivots To New Liver Programs After Setbacks - Finimize
Reversal indicators forming on Korro Bio Inc. stockBuy Signal & Accurate Entry and Exit Point Alerts - newser.com
Korro Bio Stock Crashes Over 75% After-Hours On Drug Failure, Downgrades And Layoffs — Yet Retail Flags ‘Buy-The-Fear’ Setup - Stocktwits
KRRO Downgraded to Hold by Jones Trading Amidst Industry Adjustm - GuruFocus
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):